FingerMotion Seeks Approval for Toxic Note Conversion and 500M Share Authorization
FNGR sits 32% above its 52-week low of $0.17 on light trading volume (0.3× avg).
Summary
FingerMotion's amended proxy seeks shareholder approval for converting two toxic convertible notes into over 19.99% of shares and increasing authorized shares to 500M, amid severe financial distress.
Key Events · Financing and Capital Events · FNGR
-
Share Issuance Proposal
Approval sought for issuance of 19.99% or more of outstanding shares upon conversion of two $5M senior secured convertible notes (May Note and August Note).
-
August Note Terms
August Note has a $0.35 fixed conversion price, a $0.06 floor price (20% of Nasdaq Minimum Price of $0.29), and includes a warrant for 4,092,993 shares.
-
Authorized Share Increase
Proposal to increase authorized common shares from 200M to 500M, providing flexibility for future issuances but enabling further dilution.
-
Dilution Risk
If both notes convert at the floor price, the company could issue over 166M shares, more than doubling the current 66.5M outstanding, causing massive dilution.
Analysis · FNGR · Technology
FingerMotion is asking shareholders to approve the conversion of two $5M senior secured convertible notes into shares exceeding 19.99% of outstanding stock, and to increase authorized shares from 200M to 500M. The August Note carries a $0.35 fixed conversion price and a $0.06 floor price, while the stock trades at $0.225 today. If approved, the conversion could massively dilute existing holders and flood the market with new shares. The company is already in distress with a 92% revenue collapse and a Nasdaq delisting notice, making this vote critical for survival but highly dilutive.
At the time of this filing, FNGR was trading at $0.23 on NASDAQ in the Technology sector, with a market capitalization of approximately $13.5M. The 52-week trading range was $0.17 to $2.20. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.